摘要
目的探讨多房囊性肾细胞癌(multilocular cystic renal cell carcinoma,MCRCC)的临床病理特征,提高对该肿瘤的认识。方法复习32例MCRCC的临床资料,观察其病理学形态和免疫表型特征,结合随访资料评价其预后。结果 32例中13例位于左肾,18例位于右肾,1例双肾;肿瘤平均最大径4.6 cm(1.0-8.0 cm);男女比为2.2∶1。11例行根治性肾全切术,21例行肾部分切除术。肿瘤均为多房囊性,缺少实体成分,囊壁内衬单层(偶为多层或小乳头状)胞质透明或淡粉染、Fuhrman核1级的瘤细胞,腔面富于薄壁血管。瘤细胞表达CK(32/32)、CK7(25/32)、EMA(32/32)、CD10(23/32)、vimentin(20/32),均不表达CD68。术后随访5-140个月,均未见复发和转移,无肿瘤相关死亡病例。结论 MCRCC的瘤细胞核级低、无实性瘤巢;囊壁腔面衬覆胞质透亮或淡粉染细胞伴丰富薄壁血管是诊断线索,免疫表型有助于诊断,患者一般预后良好。
Purpose To investigate the clinicopathological features of multilocular cystic renal cell carcinoma( MCRCC),and to improve the understanding of this disease. Methods Thirty-two of MCRCC were studied by clinic data,pathological features and immunophenotype. All the thirty-two cases were followed up. Results In this study,thirty-two patients were diagnosed as MCRCC with a male-to-female ratio of 2. 2 ∶ 1,thirteen of whom had the tumor in the left kidney,eighteen in the right kidney,another in the double kidneys. The mean of tumor diameter was 4. 6 cm( 1. 0 ~ 8. 0 cm). Eleven patients underwent radical nephrectomy while the other 21 patients received nephron sparing surgery. Microscopically,all the cases were multiocular,lined in the cyst wall by a single layer of tumor cells with the clear or pale cytoplasm and Fuhrman grade 1 nuclei. Occasionally,the lining consisted of several layers of tumor cells or a few small papillae were present. The linings of the cyst wall were rich in thin-wall blood vessels. Immunohistochemically,the tumor cells were positive for CK( 32 /32),CK7( 25 /32),EMA( 32 /32),CD10( 23 /32) and vimentin( 20 /32),while negative for CD68. Conclusions MCRCC is characteristic by low grade nuclei,lacking solid nodules,and in the cyst wall,and has a favourable prognosis. The rich in thin-wall blood vessels and the lining cells with the clear or pale cytoplasm are diagnosis clues.
出处
《临床与实验病理学杂志》
CAS
CSCD
北大核心
2014年第9期1004-1006,共3页
Chinese Journal of Clinical and Experimental Pathology
关键词
肾肿瘤
多房囊性肾细胞癌
病理特征
鉴别诊断
预后
renal neoplasm
multilocular cystic renal cell carcinoma
pathological features
differential diagnosis
prognosis